Projects funded by the NCN
CBR1-dependent metabolism and ABCB1-dependent effux of doxorubicin - search for a novel mechanism of reversing resistance of cancer cells
2017/25/N/NZ7/01382
Keywords:
resistance drug metabolism P-glycoprotein chemosensitizing ABCB1 inhibitors
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ1_1: Molecular biology
- NZ5_7: Human disease treatment
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 13 - announced on 2017-03-15
Amount awarded: 180 000 PLN
Project start date (Y-m-d): 2018-01-26
Project end date (Y-m-d): 2021-09-25
Project duration:: 44 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.